2024 July 08, 2024 Memo Therapeutics AG AG appoints Paul Carter as Chairperson May 07, 2024 Memo Therapeutics Increases Series C Financing To CHF 45 Million April 16, 2024 TriEye And Vertilas Partner To Demonstrate 1.3μm VCSEL-Driven SWIR Sensing Solutions March 25, 2024 Adtran And Vertilas Answer AI Demands With Industry-First Ultra-Low-Power 100G PAM4 Single-Mode VCSEL Technology February 05, 2024 Memo Therapeutics AG Strengthens Management Team